Question 38107 — pharmacy and medications

Summary

Ms. Sabine Thillaye draws the attention of the Minister of Solidarity and Health to the request from the Association for the Right to Die with Dignity (ADMD), to the availability of midazolam in town pharmacies and for general practitioners. Following the recommendations of the High Authority for Health (HAS), Agnès Buzyn, then Minister of Health, announced on February 10, 2020 the modification of the marketing authorization midazolam market, within four months, so that this product is made available to doctors in town pharmacies. This is to enable the application of law no. 2016-87 Leonetti Claeys of February 2, 2016 to patients who have chosen an end of life at home. This law recognizes the patient's right, under conditions, to deep and continuous sedation until death to relieve unnecessary suffering. Midazolam is here recognized by the HAS as the recommended first-line drug (recommendation published on February 10, 2020). However, it must be noted that to date this product is still not available in city pharmacies, which do not have the necessary authorization to order it. The delivery of midazolam in community care is therefore not carried out in practice. Also, she questions him in order to know the concrete solutions that could be proposed to make midazolam available in community pharmacies and that, where appropriate, general practitioners can guarantee that patients can choose to end their days at home with support.

Machine translation from French. The official text remains authoritative.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

No documents linked.

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.